| |
| |
|
| Insider
Information: |
Munshi Amit |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
902,630 |
|
|
Indirect Shares
|
177,083 |
|
|
| Direct
Value |
$4,703,173 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,079,713 |
|
|
| Total
Value |
$4,703,173 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 68.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epirus Biopharmaceuticals Inc |
EPRS |
Chief Executive Office... |
2015-07-02 |
120,453 |
2016-02-27 |
177,083 |
Premium* |
|
|
Arena Pharmaceuticals Inc |
ARNA |
President and CEO, Dir... |
2022-03-11 |
0 |
2016-09-30 |
0 |
Premium* |
|
|
Galecto Inc. |
GLTO |
Director |
2020-11-02 |
4,793 |
2020-11-02 |
0 |
Premium* |
|
|
Zura Bio Ltd |
ZURA |
|
2024-04-22 |
777,384 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EPRS |
Epirus Biopharmaceuticals... |
Chief Executive Officer |
• • – |
2014-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
69,253 |
69,253 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2016-09-30 |
4 |
A |
$1.41 |
$881 |
D/D |
625 |
625 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2016-12-30 |
4 |
A |
$1.21 |
$756 |
D/D |
625 |
1,250 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2017-03-31 |
4 |
A |
$1.24 |
$775 |
D/D |
625 |
1,875 |
0 |
- |
|
| GLTO |
Galecto Inc. |
Director |
– • – |
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,793 |
4,793 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,800 |
36,550 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
85,847 |
125,397 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-02-05 |
4 |
AS |
$50.00 |
$356,450 |
D/D |
(7,129) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-02-13 |
4 |
AS |
$55.00 |
$836,000 |
D/D |
(15,200) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-05-21 |
4 |
AS |
$55.00 |
$2,750,000 |
D/D |
(50,000) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-05-22 |
4 |
AS |
$56.67 |
$2,022,608 |
D/D |
(34,800) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-06-02 |
4 |
AS |
$65.00 |
$3,250,000 |
D/D |
(50,000) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-06-03 |
4 |
AS |
$67.36 |
$3,427,236 |
D/D |
(50,000) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-08-28 |
4 |
AS |
$70.00 |
$3,500,000 |
D/D |
(50,000) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-08-31 |
4 |
AS |
$70.10 |
$3,505,035 |
D/D |
(50,000) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2020-12-08 |
4 |
AS |
$70.00 |
$456,198 |
D/D |
(6,517) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2021-01-12 |
4 |
AS |
$73.90 |
$1,117,569 |
D/D |
(14,877) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2021-01-15 |
4 |
AS |
$80.19 |
$4,011,976 |
D/D |
(50,000) |
7,750 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2021-01-19 |
4 |
AS |
$80.14 |
$4,006,760 |
D/D |
(50,000) |
7,750 |
0 |
% |
|
| EPRS |
Epirus Biopharmaceuticals... |
Chief Executive Officer |
• • – |
2015-09-18 |
4 |
B |
$5.99 |
$59,860 |
I/I |
10,000 |
130,453 |
2.66 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Chief Executive Officer |
• • – |
2015-09-21 |
4 |
B |
$6.19 |
$61,900 |
I/I |
10,000 |
140,453 |
2.66 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Chief Executive Officer |
• • – |
2015-12-09 |
4 |
B |
$4.07 |
$53,683 |
I/I |
13,190 |
153,643 |
2.66 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Chief Executive Officer |
• • – |
2015-12-15 |
4 |
B |
$2.87 |
$23,158 |
I/I |
8,069 |
161,712 |
2.58 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Chief Executive Officer |
• • – |
2015-12-16 |
4 |
B |
$2.80 |
$23,156 |
I/I |
8,270 |
169,982 |
2.58 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
President and CEO |
• • – |
2017-04-26 |
4 |
B |
$1.41 |
$70,500 |
D/D |
50,000 |
51,875 |
2.81 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
